x

Search for a diagnostic test

* (*) mandatory field

57 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation
;

SWITZERLAND

Suisse Romande
SION

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B*27 genotyping)
Institut Central des Hôpitaux (ICH)
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation
Molecular analysis of HLAB27 - Susceptibility to ankylosing spondylitis
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

FRANCE

PAYS DE LA LOIRE
NANTES

Accreditation
HLA-A and HLA-B genotyping by PCR SSP or PCR SSO
Etablissement Français du Sang - Pays de Loire
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Accreditation
Diagnosis of predisposition to ankylosing spondylarthritis (HLA-B27 gene)
Groupe Hospitalier Paris Saint-Joseph
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

UNITED KINGDOM

Greater London
LONDON

Accreditation
Molecular diagnosis of susceptibility to ankylosing spondylitis (HLA-B27)
The Doctors Laboratory Ltd
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

FRANCE

HAUTS-DE-FRANCE
LILLE

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (search for HLA-B27 by PCR-SSO)
CHU de Lille - Centre de Biologie Pathologie Génétique
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

FRANCE

AUVERGNE-RHONE-ALPES
DÉCINES CHARPIEU

Accreditation
Diagnosis of susceptibility to Ankylosing spondylitis (HLA-B gene)
Établissement Français du Sang - Auvergne Rhône-Alpes
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Accreditation
Diagnosis of susceptibilty to ankylosing spondylitis (HLA-B gene)
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene)
CHU Paris - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene ; LCT)'
Établissement Français du Sang - PACA-Corse
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), PCR based techniques

FRANCE

GRAND-EST
SAINT-DIÉ DES VOSGES

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene)
LABORATOIRE BIOLAM-BIOMER
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
SAINT-MANDÉ

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B27 genotyping)
Hôpital d'Instruction des Armées Bégin
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

BRETAGNE
BREST

Accreditation
Diagnosis of predisposition to ankylosing spondylitis (HLA-B gene)
CHU de Brest - Hôpital de la Cavale Blanche
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

AUVERGNE-RHONE-ALPES
LA TRONCHE

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene: PCR-SSO)
Établissement Français du Sang - Rhône Alpes - Grenoble
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

GERMANY

Bayern
MARTINSRIED/PLANEGG

Accreditation
Diagnosis of HLA-B - susceptibility to Behcet's disease, Stevens-Johnson syndrome and ankylosing spondylitis
MVZ Martinsried GmbH
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

FRANCE

BRETAGNE
RENNES

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B27 genotyping)
Établissement Français du Sang - Bretagne
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing, PCR based techniques

SWITZERLAND

Suisse Romande
LAUSANNE

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B*27 genotyping)
Synlab Lausanne
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis disease (HLA-B gene)
Laboratoire Cerba
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

FRANCE

AUVERGNE-RHONE-ALPES
LYON

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B27 gene)
Eurofins Biomnis
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

AUVERGNE-RHONE-ALPES
PIERRE-BENITE

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B*27)
CHU de Lyon HCL - GH Sud
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B*27 gene)
Établissement Français du Sang - Bourgogne/Franche-Comté
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation
Molecular analysis of HLAB27 - Susceptibility to ankylosing spondylitis
laboratoriumsmedizin köln - Dres. med. Wisplinghoff und Kollegen
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

AUVERGNE-RHONE-ALPES
LYON

Accreditation
Diagnosis of ankylosing spondylitis (HLA-B gene)
Laboratoire Alpigene
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

AUVERGNE-RHONE-ALPES
LYON

Accreditation
HLA-A and HLA-B genotyping by PCR SSP or PCR SSO
Laboratoire Alpigene
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

FRANCE

GRAND-EST
STRASBOURG

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene)
Établissement Français du Sang - Grand Est
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

PAYS DE LA LOIRE
ANGERS

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene)
Établissement Français du Sang - Angers
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

FRANCE

NOUVELLE AQUITAINE
POITIERS

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene)
Établissement Français du Sang - Poitiers
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

PAYS DE LA LOIRE
SAINT-HERBLAIN

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B27 genotyping)
CYTOGEN
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis(HLA-B27 gene)
Laboratoire de biologie médicale GEN-BIO
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

CENTRE-VAL DE LOIRE
TOURS

Accreditation
Diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene)
Établissement Français du Sang - Centre Atlantique
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation
Genotyping of HLA-A and HLA-B genes by PCR SSP or PCR SSO
Laboratoire de biologie médicale GEN-BIO
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation
Diagnosis of predisposition to ankylosing spondylitis (HLA-B27 gene)
CHU de Clermont-Ferrand - Hôpital Gabriel Montpied
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation
Diagnosis of HLA related diseases (HLA typing)
Etablissement Français de Sang
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), PCR based techniques

FRANCE

NORMANDIE
BOIS GUILLAUME

Accreditation
Diagnosis of HLA related diseases (HLA typing)
EFS HFNO
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), PCR based techniques

FRANCE

BRETAGNE
QUIMPER

Accreditation
Diagnosis of predisposition to ankylosing spondylitis (HLA-B27 gene)
CHI de Cornouaille
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

CZECH REPUBLIC

South Moravia
HODONIN

Accreditation
Molecular diagnosis of susceptibility to ankylosing spondylitis (HLBA-B*27 genotyping)
Chemila, spol. s r.o.
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

CANADA

Terre-Neuve-et-Labrador
ST. JOHN'S

Accreditation
Molecular Analysis for Susceptibility to Ankylosing Spondylitis (HLAB27)
Health Sciences Centre
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

GERMANY

Hamburg
HAMBURG

Molecular analysis of HLAB27 - Susceptibility to ankylosing spondylitis
Gemeinschaftspraxis für Humangenetik GbR
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

ITALY

LAZIO
ROMA

Molecular diagnosis of suceptibility to ankylosing spondylitis (HLA-B gene)
Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

TOSCANA
PRATO

Molecular diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene)
USL4 - Nuovo Ospedale Santo Stefano
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

ITALY

CAMPANIA
NAPOLI

Diagnosis of susceptibility to seronegative spondyloarthritis (gene HLA-B)
Biotecnologie Avanzate Srl
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

FRANCE

NOUVELLE AQUITAINE
LIMOGES

Diagnosis of susceptibility to ankylosing spondylarthritis (search of HLA-B27 by PCR-SSO)
CHU de Limoges - Hôpital Dupuytren
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

Diagnosis of susceptibility to ankylosing spondylitis (HLA-B27 genotyping)
CHU de Bordeaux-GH Pellegrin
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Diagnosis of susceptibility to ankylosing spondylitis (search for HLA-B27 by PCR-SSP)
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

ITALY

SICILIA
AVOLA

Diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene)
Laboratori Campisi s.r.l.
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis
Technique(s) : Array based techniques

GERMANY

Sachsen
DRESDEN

Molecular analysis of HLAB27 - Susceptibility to ankylosing spondylitis
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

ITALY

MOLISE
POZZILLI

Molecular diagnosis of susceptibility to ankylosing spondylitis (HLA-B 27 gene)
Istituto Neurologico Mediterraneo - IRCCS Neuromed
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

GRAND-EST
REIMS

Diagnosis of susceptibility to ankylosing spondylitis (HLA-B27 gene)
CHU de Reims - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

SWITZERLAND

Suisse Romande
LAUSANNE

Diagnosis of susceptibility to ankylosing spondylitis (HLA-B*27 genotyping)
Gene Predictis SA
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

GERMANY

Rheinland-Pfalz
MAINZ

Molecular analysis of HLAB27 - Susceptibility to ankylosing spondylitis
Universitätsmedizin Mainz
Purpose(s) : Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

ITALY

EMILIA ROMAGNA
FERRARA

Diagnosis of susceptibility to seronegative spondyloarthropathies (HLA-B gene)
A.O.U. Sant'Anna - Polo Chimico-Bio-Medico
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

CZECH REPUBLIC

Usti nad Labem
USTI NAD LABEM

Search for susceptibility to ankylosing spondylarthritis (HLA-B gene)
Masaryk hospital
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

SLOVENIA

SLOVENIA
MARIBOR

Molecular diagnosis of susceptibility to ankylosing spondylarthritis (HLA-B27)
Maribor general hospital
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Olomouc
OLOMOUC

Molecular diagnosis of susceptibility to ankylosing spondylitis (HLA-B*27 genotyping)
University hospital Olomouc
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Moravia-Silesia
OSTRAVA-PORUBA

Molecular diagnosis of susceptibility to ankylosing spondylitis (HLA-B*27 gentotyping)
Laboratory of Forensic Genetics, Laborator forenzni genetiky, spol. s r.o.
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

ITALY

PUGLIA
LECCE

Molecular diagnosis of susceptibility to ankylosing spondylitis (HLA-B gene)
Presidio Ospedaliero "Vito Fazzi" - ASL LE
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

PORTUGAL

CENTRO
OEIRAS

Analysis of susceptibility for Ankylosing spondylitis (HLA-B gene, 27 allele)
Laboratório de Análises Clínicas Dr. Joaquim Chaves
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics